|
FAM200A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.318000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.987800E-01 |
| Normal-vs-Stage2 |
4.107000E-01 |
| Normal-vs-Stage3 |
2.525600E-01 |
| Normal-vs-Stage4 |
9.440400E-01 |
| Stage1-vs-Stage2 |
6.237000E-01 |
| Stage1-vs-Stage3 |
1.227830E-01 |
| Stage1-vs-Stage4 |
6.725600E-01 |
| Stage2-vs-Stage3 |
1.505400E-01 |
| Stage2-vs-Stage4 |
5.640400E-01 |
| Stage3-vs-Stage4 |
5.865200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.595000E-01 |
| Normal-vs-AfricanAmerican |
4.021400E-01 |
| Normal-vs-Asian |
6.113800E-01 |
| Caucasian-vs-AfricanAmerican |
8.955600E-01 |
| Caucasian-vs-Asian |
5.221200E-01 |
| AfricanAmerican-vs-Asian |
5.259800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.068180E-01 |
| Normal-vs-Female |
8.108000E-01 |
| Male-vs-Female |
1.702990E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.658000E-01 |
| Normal-vs-Extreme_Weight |
1.462570E-01 |
| Normal-vs-Obese |
4.368400E-01 |
| Normal-vs-Extreme_Obese |
9.896000E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.480400E-01 |
| Normal_Weight-vs-Obese |
4.762000E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.245800E-01 |
| Extreme_Weight-vs-Obese |
6.148200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.716200E-01 |
| Obese-vs-Extreme_Obese |
7.370000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.518800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.020300E-02 |
| Normal-vs-Age(61-80Yrs) |
9.773200E-01 |
| Normal-vs-Age(81-100Yrs) |
8.368800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.869000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.413400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.064400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.691600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.286800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.436600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.02419999999481E-05 |
| Normal-VS-Type2 PRCC |
1.65655999999625E-05 |
| Normal-VS-KIRP CIMP |
9.995400E-04 |
| Normal-VS-Unclassified PRCC |
6.802400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.05151476204446E-14 |
| Type1 PRCC-VS-KIRP CIMP |
1.57298999999833E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
6.100700E-03 |
| Type2 PRCC-VS-KIRP CIMP |
9.628400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.120230E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.049900E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.147600E-01 |
| Normal-vs-N1 |
2.400400E-01 |
| Normal-vs-N2 |
3.357900E-02 |
| N0-vs-N1 |
9.759600E-01 |
| N0-vs-N2 |
5.396800E-01 |
| N1-vs-N2 |
4.506600E-01 |
|
|
